Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Compact case
Case
-
Reference no. UVA-E-0075
Authors: Jeanne M Liedtka
Published by: Darden Business Publishing
Published in: 1991

Abstract

The B case opens with Wellcome's announcement of the wholesale price of AZT. The remainder of this case chronicles the responses of various groups involved in the AIDs crisis-Wellcome PLC investors, US government officials, members of the medical community, and AIDs activists. The B case concludes with Wellcome's defense of its pricing rationale.

About

Abstract

The B case opens with Wellcome's announcement of the wholesale price of AZT. The remainder of this case chronicles the responses of various groups involved in the AIDs crisis-Wellcome PLC investors, US government officials, members of the medical community, and AIDs activists. The B case concludes with Wellcome's defense of its pricing rationale.

Related